Exploring New Treatment Strategies for Immune Checkpoint Blockade in Melanoma

In this activity with downloadable slides review expert discussion on the integration of immune checkpoint inhibitors into the adjuvant and neoadjuvant settings for patients with melanoma.

Share

Program Content

Activities

Adjuvant Immunotherapy
Adjuvant Treatment of Resected Node-Positive Melanoma With Immune Checkpoint Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 29, 2019

Expires: March 27, 2020

Neoadjuvant and Upfront Immunotherapy
Contemporary Treatment Strategies for Resectable Melanoma: Is Earlier Immune Checkpoint Blockade Better?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 29, 2019

Expires: March 27, 2020

No activities added yet

Faculty

cover img faculity

Rodabe Amaria, MD

Assistant Professor
Department of Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Michael B. Atkins, MD

Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

cover img faculity

Ahmad Tarhini, MD, PhD

Assistant Professor of Medicine
Department of Medicine/Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Merck Oncology